Adagrasib Plus Cetuximab May Provide Clinical Benefit in Patients With KRASG12C-mutated Colorectal Cancer
SAN DIEGO – A combination of the KRASG12C inhibitor adagrasib (Krazati) and the anti-epidermal growth factor receptor (EGFR) antibody...
Search/Filter
Loading...
A Biologic Drug-Device Combination Immunotherapy Shows Promise for Patients with Metastatic Prostate Cancer
The investigational therapy uses a cold-temperature probe to kill a portion of prostate cancer cells and release tumor-specific neoantigens...
Fewer Than Half of Accelerated Approval Drugs Showed Clinical Benefit in Confirmatory Trials After Five Years
SAN DIEGO – Of the 46 cancer drugs that the U.S. Food and Drug Administration (FDA) granted accelerated approval...
Accelerated Aging May Increase the Risk of Early-onset Cancers in Younger Generations
SAN DIEGO – Accelerated aging was more common in recent birth cohorts and was associated with increased incidence of...
Immune Response to Investigational RNA Vaccine for Pancreatic Cancer Continues to Correlate with Clinical Benefit
Results are from a median follow-up of three years SAN DIEGO – An adjuvant treatment regimen that included autogene...
Bispecific Immune Checkpoint Inhibitor Improves Survival in Gastric Cancer Patients Regardless of PD-L1 Status
SAN DIEGO – The PD-1/CTLA-4 bispecific antibody cadonilimab plus chemotherapy improved progression-free survival and overall survival in patients with...
Some Breast Cancer Survivors May Safely De-escalate Mammography Three Years After Surgery
SAN ANTONIO – Women 50 or older who de-escalated to less-frequent mammography three years after curative surgery for early-stage...
Skipping Adjuvant Radiotherapy May Not Impact Risk of Recurrence or Progression in Patients with Low-risk DCIS
MRI and a DCIS gene profile were used to stratify patients for treatment SAN ANTONIO – Patients with low-risk...
Potentially Targetable Fusion RNAs May Be More Common in Metastatic Breast Cancer Than Previously Realized
SAN ANTONIO – Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique...
Patients with HR-positive Breast Cancer May Use Fertility Preservation and Assisted Reproductive Technologies Without Increased Risk of Recurrence
Study examined pregnancy and cancer outcomes among patients who paused endocrine therapy to conceive SAN ANTONIO – Using fertility...